As of 03 Nov 2026 19:24 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.
Presentations, as stated in the latest recorded notice
Each line is re-expressed from MSN/2024/087 (22 Aug 2024): the product named, the status the source stated, and the expected-back phrase kept as written. Not the source's sentence, and not an observation of stock.
| Presentation | Status, as stated | Expected back, as stated | Stated in |
|---|---|---|---|
| Naltrexone 50mg tablets (Accord)affected product · inferred from phrasing | Limited supply, as stated | early September 2024precision: early in the month · window end 10 Sep 2024, derived from “early September 2024” | notice of 22 Aug 2024 |
| Naltrexone (Adepend®) 50mg tablets (AOP Orphan)affected product · inferred from phrasing | Out of stock, as stated⚠ the source line states more than one status — first stated shown | mid-September 2024precision: mid-month · window end 20 Sep 2024, derived from “mid-September 2024” | notice of 22 Aug 2024 |
| Naltrexone 50mg tablets (AOP Orphan)named by the source as remaining available · inferred from phrasing | Stated as available | — not stated for this line | notice of 22 Aug 2024 |
Protocol in force
No Serious Shortage Protocol matched to this name is in force on the NHSBSA register. Matching is by name until identifier coding lands.
Named in the source as remaining available
- Naltrexone 50mg tablets (AOP Orphan) — named by the source as remaining available (inferred from phrasing)
Only names the source itself listed, as it listed them (source post ↗). No substitution, dosing or counselling advice is given here or implied.
Identifiers — Naltrexone
Grouping under review The name on this page has not been matched to one BNF chemical with enough confidence to assert it; nothing here is grouped until a reviewer confirms it.
BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence not asserted — grouping under review where marked
BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.
History
One supply notification on record, 22 Aug 2024. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.
| Issued | Notice | Kind | Tier | Reference |
|---|---|---|---|---|
| 22 Aug 2024 | Medicine Supply Notification: Naltrexone 50mg tablets | Supply notification | Tier 2 | MSN/2024/087 |
Also recorded under
No other name appears in this medicine's notice titles. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.
Scotland — separate record
NHS Scotland issues its own Medicine Supply Alert Notices. These match this medicine's name; they are shown beside, never added to, the England record.
- MSAN(2024)49 Naltrexone 50mg tablets · issued 28 Aug 2024 · valid until late October 2024, as stated · matched by name PDF ↗